Mihaela Roşu

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Dose reconstruction in deforming lung anatomy: Dose grid size effects and clinical implications

Mihaela Roşu, Indrin J. Chetty, James M. Balter et al. · Medical Physics · 2005 · 116 citations · Full text

Medicine, Radiology, Biomedical Imaging +16

Reporting and analyzing statistical uncertainties in Monte Carlo–based treatment planning

Indrin J. Chetty, Mihaela Roşu, Marc L. Kessler et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 96 citations

Medicine, Radiation Oncology, Stochastic Modeling +15

Effects of Pilates, McKenzie and Heckscher training on disease activity, spinal motility and pulmonary function in patients with ankylosing spondylitis: a randomized controlled trial

Mihaela Roşu, Ionuţ Ţopa, Rodica Chirieac et al. · Rheumatology International · 2013 · 91 citations

Medicine, Kinesiology, Rehabilitation Medicine +15